Beam Therapeutics Inc. (BEAM) vs Dyne Therapeutics, Inc. (DYN)

A side-by-side comparison of Beam Therapeutics Inc. and Dyne Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — BEAM vs DYN

growth of $100 · dividends reinvested · last 6y
BEAM -10.8% (-1.9%/yr)DYN -35.4% (-7.0%/yr)BEAM compounded faster over this window
0100200300400Start $100202120222023202420252026$89$65
BEAM DYN

BEAM vs DYN: by the numbers

  • •DYN is the larger company ($2.83B vs $2.66B market cap).
  • •Both run net losses; DYN's is the smaller (0.00% vs -54.75% net margin).

Metrics side by side

Valuation

MetricBEAMDYN
P/S ratio17.04N/A
P/B ratio2.494.03

Profitability

MetricBEAMDYN
Gross margin84.05%0.00%
Operating margin-274.57%0.00%
Net margin-54.75%0.00%
ROE-8.00%-73.97%
ROIC-28.96%-58.28%

Growth (annualized)

MetricBEAMDYN
Revenue CAGR (5Y)479.04%N/A
Total return CAGR (5Y)-21.41%-0.38%

Frequently asked

How have BEAM and DYN total returns compared?
Over the past 5 years, BEAM delivered -21.41% and DYN delivered -0.38% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.